Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus
Su, Fang; Xiao, Weiguo; Yang, Pingting; Chen, Qingyan; Sun, Xiaojie; Li, Tienan.
An. bras. dermatol
; 92(4): 466-469, July-Aug. 2017. tab
Artículo
en Inglés
| LILACS | ID: biblio-887005
Abstract
Background:
The clinical significance of anti-neutrophil cytoplasmic antibodies in patients with new-onset systemic lupus erythematosus, especially in systemic disease accompanied by interstitial lung disease remains to be elucidated.Objectives:
This study was designed to investigate the role of anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus patients.Methods:
A hundred and seven patients with new-onset SLE were enrolled. Presence of anti-neutrophil cytoplasmic antibodies in the sera was assessed by indirect immunofluorescence as well as enzyme linked immunosorbent assay against proteinase-3 and myeloperoxidase. Clinical features and laboratory parameters of patients were also recorded. All patients were subjected to chest X-ray, chest high-resolution computed tomography and pulmonary function test.Results:
Forty-five systemic lupus erythematosus patients (45/107, 42%) were seropositive for anti-neutrophil cytoplasmic antibodies. Compared with anti-neutrophil cytoplasmic antibodies-negative patients, the anti-neutrophil cytoplasmic antibodies-positive patients had significantly higher incidence of renal involvement, anemia, and Raynaud's phenomenon as well as decreased serum level of complement 3/complement 4 and elevated erythrocyte sedimentation rate. In addition, there was a positive correlation between serum anti-neutrophil cytoplasmic antibodies level and disease activity of systemic lupus erythematosus. Furthermore, prevalence of interstitial lung disease in the anti-neutrophil cytoplasmic antibodies -positive patients (25/45, 55.6%) was obviously higher than that in the anti-neutrophil cytoplasmic antibodies-negative patients (15/62, 24.2%). Studylimitations:
The sample size was limited and the criteria for screening new-onset systemic lupus erythematosus patients might produce bias.Conclusions:
The level of anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus patients correlates positively with the disease activity and the prevalence of interstitial lung disease.Asunto(s)
Humanos Masculino Femenino Adolescente Adulto Persona de Mediana Edad Adulto Joven Enfermedades Pulmonares Intersticiales/inmunología Anticuerpos Anticitoplasma de Neutrófilos/sangre Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/inmunología Lupus Eritematoso Sistémico/inmunología Pronóstico Ensayo de Inmunoadsorción Enzimática Tomografía Computarizada por Rayos X/métodos Estudios Transversales Enfermedades Pulmonares Intersticiales/etiología Técnica del Anticuerpo Fluorescente Indirecta Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/complicaciones Lupus Eritematoso Sistémico/diagnóstico por imagen Neutrófilos/enzimología
Biblioteca responsable:
BR1.1
powered by iAHx-2.18-89
Biblioteca Virtual en Salud